A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers
Ocellaris Pharma, Inc.
Ocellaris Pharma, Inc.
Actym Therapeutics, Inc.
Incyte Corporation
Telix Pharmaceuticals (Innovations) Pty Limited
pharmaand GmbH
Eli Lilly and Company
Cambridge University Hospitals NHS Foundation Trust
CureOne
University Health Network, Toronto
GOG Foundation